Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (Aim 2)
Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (Aim 2)
The overall objective of this study is to evaluate the public health impact of targeted
 antimalarials subsidies through scale-up by determining the community-wide effects of
 targeting an antimalarial subsidy through a partnership between Community Health Volunteers
 (CHVs) and the private retail sector. The primary hypothesis to be tested is that offering a
 fixed-price voucher that reduces the cost for artemisinin combination therapy (ACT) purchase
 in the retail sector conditional on a positive malaria test (targeted subsidy) can improve
 uptake of testing for malaria and will increase the proportion of fevers tested for malaria
 before treatment. The study will be carried out in two sub-counties in Kenya with similar
 malaria burden but different access to health services; the investigators will use a
 cluster-randomized design to assign community units (CUs) in each sub-county to either an
 intervention or control arm. CHVs will be trained to use malaria rapid diagnostic tests
 (RDTs) to diagnose malaria in household members with documented or reported fever; households
 in intervention CUs will be informed of the intervention and encouraged to contact the CHV
 for any febrile illness in the home. There are minimal risks associated with receiving an
 RDT. Households with a positive RDT will be given a serialized voucher that will entitle the
 holder to purchase a quality assured ACT in the retail sector at a reduced, fixed price. The
 primary and secondary outcome measures will be compared at baseline and 12 months
 post-baseline through population-based surveying. The primary aim is to determine whether
 there is significant difference between the 2 study arms in the proportion of clients with
 fever who are tested prior to any treatment after adjusting for relevant covariates.
INCLUSION CRITERIA

 Intervention participation criteria:

 -  Client is older than 1 year

 -  Client has fever or history of fever or feeling unwell with a malaria-like illness
 within the last 2 days

 -  Client or their parent/legal guardian (if under 18) consents to participate

 Cross sectional survey participation criteria:

 -  Household representative in the intervention or control arm

 -  At least one member in the respondent's household with a history of fever or feeling
 unwell with a malaria like illness within the last four weeks

 -  Respondent is older than 18 years

 EXCLUSION CRITERIA

 Intervention exclusion criteria:

 -  Client has signs of severe disease or other problem requiring immediate referral to a
 health facility

 -  Client has already visited a health facility, taken or purchased antimalarials for the
 current illness.

 Cross sectional survey exclusion criteria:

 • Households not in the intervention or control arms